Indian Pharmaceutical Alliance(formerly Indian Pharmaceutical Association)

DeRisk Affordable Medicine Supply Chain; seeking Partnership with US Government & Allies

🤖

AI Overview

With $1.0M in lobbying spend across 13 quarterly filings, Indian Pharmaceutical Alliance(formerly Indian Pharmaceutical Association) is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2024 to 2025.

$1.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2024	$75K
2025	$945K

Issues Lobbied

Health Issues Trade Homeland Security Defense Disaster Planning Medicare/Medicaid

Lobbying Firms

Medsecurean.com

Lobbyists

Kathleen Jaeger

Government Agencies Targeted

These are the government entities that Indian Pharmaceutical Alliance(formerly Indian Pharmaceutical Association) disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESNatl Security Council (NSC)SENATEState, Dept of (DOS)U.S. Trade Representative (USTR)White House OfficeFederal Trade Commission (FTC)Commerce, Dept of (DOC)Office of Management & Budget (OMB)Treasury, Dept ofNatl Economic Council (NEC)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Trade, Homeland Security, Defense, Disaster Planning and 1 more

IPA seeks a sectoral trade agreement with the US to derisk both countries' affordable medicine supply chain. The partnership construct is intended to be expanded to include other trusted allies.